Delivery Order SPE2DB20D2104-SPE2DB23FT61T
- Not listed
- This federal contract award is for the delivery of 24,000 units of Creon DR 100S capsules to the Defense Logistics Agency (DLA). The contract, valued at $3,081.38, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 14, 2023. The contract is a firm fixed-price delivery order with a completion date of June 15, 2023. The award was made through open competition, as there was no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc.,...
- This federal contract award is for the delivery of 6,000 units of Creon DR capsules (100 count bottles) to the Defense Logistics Agency (DLA). The $1,983.12 fixed-price delivery order was issued on October 26, 2021 to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of October 27, 2021 and was not subject to any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of 36,000 units of Creon DR 100s capsules to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $5,649.84 and a completion date of December 22, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
- This federal contract award is for the delivery of 36,000 units of the pharmaceutical product CREON DR capsules, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,818.18 firm fixed-price delivery order has a completion date of February 24, 2025 and was awarded on February 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of 24,000 unit capsules of the pharmaceutical product Creon DR to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has a firm fixed price of $13,165.23 and a completion date of April 17, 2024. It is a delivery order contract with no set-aside designation. Amerisourcebergen holds a larger Indefinite...
- This federal contract award is for the delivery of 36,000 units of the pharmaceutical product CREON DR 100S capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a firm fixed price of $3,111.27. The award is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025, for a comprehensive range...
- This federal contract award is for the delivery of 36,000 units of Creon DR 36,000 unit capsules from the prime contractor Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The contract has a firm fixed price of $8,557.04 and a performance period through April 30, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the...
- This federal contract award is for the delivery of 36,000 unit capsules of the pharmaceutical product CREON DR to the United States government. The contract, valued at $8,914.46, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a Firm Fixed Price Delivery Order contract with a completion date of September 21, 2023. The contract does not have a set-aside designation, indicating it was...
- This federal contract award is for the delivery of 24,000 unit capsules of the pharmaceutical product CREON DR to the Defense Logistics Agency (DLA), a component of the Department of Defense (DOD). The contract, valued at $12,975.74, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate...
- This federal contract award is for the delivery of 12,000 unit capsules of the pharmaceutical product CREON DR. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,741.74 and is a firm fixed price delivery order contract with a completion date of February 24, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FT61TDelivery Order
This federal contract award is for the delivery of 36,000 units of Creon DR 100S capsules to the Defense Logistics Agency (DLA). The contract has a firm fixed price of $9,866.07 and a completion date of May 23, 2023. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 5/22/23 |